Elsevier

Biomedicine & Pharmacotherapy

Volume 90, June 2017, Pages 455-465
Biomedicine & Pharmacotherapy

Ameliorative potential of Colebrookea oppositifolia methanolic root extract against experimental models of epilepsy: Possible role of GABA mediated mechanism

https://doi.org/10.1016/j.biopha.2017.03.078Get rights and content

Highlights

Abstract

Background

Colebrookea oppositifolia Smith is one of the commonly used plants to treat epilepsy by various folk medicine communities like nomadic Gujjars, Tharu and Bhoxa in sub-Himalayan regions of India.

Purpose

The present study was undertaken to evaluate the anticonvulsant activity of roots of Colebrookea oppositifolia using various experimental models of epilepsy in mice.

Methods

Petroleum ether extract of roots of C. Oppositifolia (PeCO), methanolic eCO (MeCO) and aqueous eCO (AeCO) was initially evaluated in six-hertz-seizure test in mice, the effective extract was further evaluated against maximal electroshock (MES) and pentylenetetrazole (PTZ) models in mice. In addition, the potent extract was evaluated against the PTZ model by co-administering with flumazenil (FMZ), and also evaluated for its effect on brain GABA levels in brain and NMDA-induced lethality in mice. Furthermore, the possible locomotor deficit-inducing property of the extract was evaluated by actophotometer test in mice.

Results

In six-hertz-seizure test the MeCO (25, 50, 100 and 200 mg/kg) and AeCO (50, 100, 200, 400 and 800 mg/kg) showed significant protection compared to control group, and MeCO was more potent than AeCO. Based on these outcomes, only MeCO was evaluated in MES and PTZ models. Notably, the MeCO (25, 50, 100 and 200 mg/kg) has offered significant and dose- dependent protection against MES and PTZ-induced seizures in mice. Alongside, the MeCO (100 and 200 mg/kg) showed a significant increase in GABA levels in the brain compared to control. In line with these findings, the anti-PTZ effect of MeCO (100 mg/kg, p.o.) was blocked when co-administered with flumazenil (3 mg/kg, i.p.),and in NMDA-induced mortality test, the MeCO has shown only 50% protection at 200 mg/kg dose, thus confirmed the significant role of GABA pathway. Interestingly, the MeCO did not cause significant change in locomotor activity compared to before treatment.

Conclusion

These findings suggest that MeCO possess significant anticonvulsant activity and the outcomes further confirmed the involvement of GABAergic mechanisms behind the anticonvulsant activity of MeCO.

Introduction

The scope of plant based medicines in the treatment of neurological diseases has been increasing enormously due to their wide therapeutic efficacy and greater levels of safety margin compared to synthetic class of drugs [1], [2]. In support of this many plant based medicines such as Swertia corymbosa [3], Coriandrum sativum [4], [5], Carum Carvi L. [6], Kalanchoe pinnata Lam. [7], Abies webbiana Lendl. [8], Laggera Aurita Linn. [9], Platonia insignis Mart. [10], and Dodonaea viscosa Linn [11] have been scientifically proved to possess potent anticonvulsant activity against experimental models of epilepsy. Epilepsy is a serious neurological disease affecting more than 65 million population worldwide, and each year approximately 0.2 million people are newly diagnosed with epilepsy [12], and it is estimated that close to 1 million deaths occur every year due to epilepsy [13], [14]. Currently various synthetic drugs are available for the treatment of epilepsy [15]. However, all the presently available synthetic anticonvulsant drugs are prone to cause one or more side/adverse effects like ataxia, mental confusion, sleep disturbance, anorexia, impotence, dizziness, mental slowing, impaired concentration, somnolence, aggression and so on [16], [17], [18]. Despite of copious efforts currently there is no safer and potent drug available for the treatment of epilepsy. In this context, there is an incredible scope for development of safe and potent drug for the management of epilepsy, in these lines plant based medicines are scientifically well proved for their better efficacy and also got a better edge over synthetic drugs, thus many researchers are focusing on herbal medicines to discover better and safe medicine for epilepsy [2]. In view of this, Colebrookea oppositifolia Smith (Lamiaceae), has been extensively used in the folklore medicine for the treatment of various diseases such as dermatitis, dysentery, fever, headache, peptic ulcer, hemostatic, wounds, as anti-fertility agent, fungicide, and the roots of the plant has been most widely used for the treatment of epilepsy [19], [20], [21], [22]. In line with its potential usage in folk medicine, various parts of the plant has been scientifically proven for anti-fertility [23], [24], antimicrobial [25], [26], antioxidant, [27], [28], antiulcer [29], and cardioprotective [30] activities. Additionally, relevant to the present work, various parts of Colebrookea oppositifolia is being extensively used for the treatment of epilepsy by various folk medicine practicing communities such as nomadic Gujjars, Tharu and Bhoxa in sub-Himalayan regions of India, from many decades and even now [31]. However, there is a paucity of scientific literature to support the anticonvulsant activity of the plant, therefore in the present study, we thought to evaluate the root extracts of Colebrookea oppositifolia for their possible anticonvulsant activity against experimental models of epilepsy.

Section snippets

Drugs and chemicals

Phenytoin was purchased from Sun Pharma (Mumbai, India), diazepam and flumazenil was procured from Ranbaxy (New Delhi, India), and pentylenetetrazole was purchased from Sigma-Aldrich (Bangalore, India). All the liquid chromatography (HPLC) grade solvents used in this study were procured from Merck Ltd. (Mumbai, India). All other chemicals and reagents used were of analytical grade and were purchased from HiMedia Laboratories Pvt. Ltd. (Mumbai, India)

Collection of plant material

The roots of Colebrookea oppositifolia were

Extraction of plant material

The extractive values of petroleum ether (PeCO), methanol (MeCO) and aqueous (AeCO) extracts were found to be 0.10, 3.45, and 2.73% w/w (gram by gram) respectively.

Acute oral toxicity study

Acute oral toxicity study for the plant extracts were performed as per OECD guidelines no. 425 up and down procedure. In acute toxicity studies PeCO showed central nervous system stimulation, at 550 mg/kg and higher doses exhibited clonic-tonic convulsions and death. However, MeCO and AeCO showed mild sedation and respiratory

Discussion

In this study root extracts of Colebrookea oppositifolia were assessed for antiepileptic activity in three different experimental models, namely six-hertz-seizure test, MES and PTZ models in mice.

As per the recommendations of recent anticonvulsant drug discovery program, all the extracts of Colebrookea oppositifolia (PeCO, MeCO and AeCO) were initially evaluated against six-hertz-seizure test in mice [46]. In fact, six-hertz-seizure test resembles the clinical state of limbic or partial

Conclusion

These findings demonstrate that, MeCO possess significant anticonvulsant activity, additionally MeCO showed a significant increase in GABA levels in the brain, and interestingly, the anticonvulsant action of MeCO was abolished by flumazenil, and thus confirmed that one of the possible mechanism/s behind the anticonvulsant activity of MeCO may be mediated through GABAergic pathway. Furthermore, in NMDA-induced lethality test the MeCO has showed partial protection, and thus confirmed the

Conflicts of interest

The authors declare there are no conflicts of interest.

Acknowledgements

The authors acknowledge the technical help provided by Dr. Nandakumar K, Associate Professor, Department of Pharmacology, Manipal college of Pharmaceutical sciences, Manipal. The authors greatly acknowledge the scientific and technical help provided by Ms.Vittartha Life Sciences, Bommasandra Industrial Area, Bangalore. We would like to thank Ms. Radiant Research Services Pvt Ltd., Bangalore, and Manipal college of Pharmaceutical sciences, Manipal for providing all the necessary facilities to

References (67)

  • A.E. Hernan et al.

    Antiepileptic drug treatment strategies in neonatal epilepsy

    Prog. Brain Res.

    (2016)
  • M. Shannon et al.

    Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. The Flumazenil Pediatric Study Group

    J. Pediatr.

    (1997)
  • L.J. Greenfield

    Molecular mechanisms of antiseizure drug activity at GABAA receptors

    Seizure

    (2013)
  • J. Li et al.

    Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors

    Neuropharmacology

    (2006)
  • J.D. Leander et al.

    N-methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs

    Brain Res.

    (1988)
  • S. Bent

    Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center

    J. Gen. Intern. Med.

    (2008)
  • J. Muazu et al.

    A review of traditional plants used in the treatment of epilepsy amongst the Hausa/Fulani tribes of northern Nigeria, African

    J. Traditional Complement. Altern. Med.

    (2008)
  • G. Mahendran et al.

    Evaluation of anticonvulsant, sedative, anxiolytic, and phytochemical profile of the methanol extract from the aerial parts of Swertia corymbosa (Griseb.) wight ex C.B. Clarke

    BioMed Res. Int.

    (2014)
  • A. Anaeigoudari et al.

    The effects of different fractions of Coriandrum sativum on pentylenetetrazole-induced seizures and brain tissues oxidative damage in rats

    Avicenna J. Phytomed.

    (2016)
  • R. Karami et al.

    Effects of hydroalcoholic extract of Coriandrum sativum on oxidative damage in pentylenetetrazole-induced seizures in rats

    Iran. J. Neurol.

    (2015)
  • A. Showraki et al.

    Anticonvulsant effect of the aqueous extract and essential oil of carum carvi L. seeds in a pentylenetetrazol model of seizure in mice

    Iran. J. Med. Sci.

    (2016)
  • O. Parkash et al.

    Screening of methanol extract and ethyl acetate fraction of abies webbiana lindl. for neuropharmacological activities

    Indian J. Pharm. Sci.

    (2015)
  • J.S. Junior et al.

    Evaluation of possible antioxidant and anticonvulsant effects of the ethyl acetate fraction from Platonia insignis Mart. (Bacuri) on epilepsy models

    Epilepsy Behav.: E&B

    (2011)
  • M. Brodie et al.

    Epilepsy, antiepileptic drugs, and aggression: an evidence-Based review

    Pharmacol. Rev.

    (2016)
  • A. Bell

    An unknown quantity–the worldwide prevalence of epilepsy

    Epilepsia

    (2014)
  • W.A. Hauser et al.

    Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984

    Epilepsia

    (1993)
  • M.M. Goldenberg

    Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment, P & T

    Peer- Rev. J. Formul. Manage.

    (2010)
  • M. Mula

    Third generation antiepileptic drug monotherapies in adults with epilepsy

    Expert Rev. Neurother.

    (2016)
  • S.A. Hamed

    The effect of epilepsy and antiepileptic drugs on sexual, reproductive and gonadal health of adults with epilepsy

    Expert Rev. Clin. Pharmacol.

    (2016)
  • Y. Yang et al.

    Sexual dysfunction related to antiepileptic drugs in patients with epilepsy

    Expert Opin. Drug Saf.

    (2016)
  • S. Yoganarasimhan, Medicinal Plants of India Interline Publishing Private Limited,...
  • B. Adhikari et al.

    Distribution, use pattern and prospects for conservation of medicinal shrubs in Uttaranchal state India

    J. Mt. Sci.

    (2007)
  • K. Nadkarni

    Indian Material Medica

    (1976)
  • Cited by (15)

    • Chemical characterization and cerebroprotective effect of methanolic root extract of Colebrookea oppositifolia in rats

      2018, Journal of Ethnopharmacology
      Citation Excerpt :

      Lamiaceae) has been extensively used in the traditional system of Indian medicine for the treatment of various ailments such as headache, fever, dysentery, peptic ulcer, dermatitis, wounds, hemostatic, antifungal, as anti-fertility agent, and the roots of the plant has been most widely used for the treatment of epilepsy (NadkarnI, 1976; Kritikar and Basu, 2007). In support of potential medicinal uses in folk medicine, various parts of C. oppositifolia have been shown to possesses pharmacological activities such as anticonvulsant (Viswanatha et al., 2017), antioxidant (Riaz et al., 2011; Subba and Basnet, 2014), antiulcer (Ghaisas et al., 2010), antimicrobial (Subba and Basnet, 2014), cardioprotective (Pallab et al., 2011) and anti-fertility (Gupta et al., 2001) activities. Furthermore, confined to the present work, various parts of the plant such as roots, leaves and stem (in the form of decoction and dry powder) are being extensively used for the treatment of epilepsy by various folk medicine practicing communities such as nomadic Gujjars, Tharu and Bhoxa in sub- Himalayan regions of India, from many decades and even now (Sharma et al., 2013).

    View all citing articles on Scopus
    View full text